{"id":1395,"date":"2026-07-21T13:36:32","date_gmt":"2026-07-21T11:36:32","guid":{"rendered":"https:\/\/atonco-pharma.com\/2026\/07\/21\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\/"},"modified":"2026-09-11T13:54:40","modified_gmt":"2026-09-11T11:54:40","slug":"le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible","status":"publish","type":"post","link":"https:\/\/atonco-pharma.com\/en\/2026\/07\/21\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\/","title":{"rendered":"THE LATEST ISSUE OF MABDESIGN\u2019S IMMUNOWATCH, DEDICATED TO RADIOPHARMACEUTICALS, IS NOW AVAILABLE!"},"content":{"rendered":"

This issue takes a deep dive into one of the most dynamic areas of precision oncology. MabDesign\u2019s Scientific and Business Intelligence Department kicks off the edition with an in-depth analysis of the market landscape, development pipeline, and industrial challenges shaping this consolidating sector.<\/p>\n

Leading experts then address critical topics: from bioconjugation strategies for radioimmunoconjugates to targeted alpha immunotherapy for bladder cancer, as well as the collaborative ecosystem supported by the PROMETHE association and the role of artificial intelligence in discovering novel radiotheranostic targets.<\/p>\n

Link to the original article: 2026-IW-Radiopharmaceuticals-5.pdf<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

This issue takes a deep dive into one of the most dynamic areas of precision oncology. MabDesign\u2019s Scientific and Business Intelligence Department kicks off the edition with an in-depth analysis of the market landscape, development pipeline, and industrial challenges shaping this consolidating sector. Leading experts then address critical topics: from bioconjugation strategies for radioimmunoconjugates to […]<\/p>\n","protected":false},"author":5,"featured_media":1396,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,47],"tags":[],"class_list":["post-1395","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-categorise","category-other-news"],"yoast_head":"\nTHE LATEST ISSUE OF MABDESIGN\u2019S IMMUNOWATCH, DEDICATED TO RADIOPHARMACEUTICALS, IS NOW AVAILABLE! - Atonco<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/atonco-pharma.com\/en\/2026\/07\/21\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"THE LATEST ISSUE OF MABDESIGN\u2019S IMMUNOWATCH, DEDICATED TO RADIOPHARMACEUTICALS, IS NOW AVAILABLE! - Atonco\" \/>\n<meta property=\"og:description\" content=\"This issue takes a deep dive into one of the most dynamic areas of precision oncology. MabDesign\u2019s Scientific and Business Intelligence Department kicks off the edition with an in-depth analysis of the market landscape, development pipeline, and industrial challenges shaping this consolidating sector. Leading experts then address critical topics: from bioconjugation strategies for radioimmunoconjugates to […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/atonco-pharma.com\/en\/2026\/07\/21\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\/\" \/>\n<meta property=\"og:site_name\" content=\"Atonco\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-21T11:36:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-11T11:54:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2026\/07\/Image1222.png\" \/>\n\t<meta property=\"og:image:width\" content=\"625\" \/>\n\t<meta property=\"og:image:height\" content=\"815\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Elise\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Elise\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/07\\\/21\\\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/07\\\/21\\\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\\\/\"},\"author\":{\"name\":\"Elise\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/c77adc54665cc7fe725d486b08371aaa\"},\"headline\":\"THE LATEST ISSUE OF MABDESIGN\u2019S IMMUNOWATCH, DEDICATED TO RADIOPHARMACEUTICALS, IS NOW AVAILABLE!\",\"datePublished\":\"2026-07-21T11:36:32+00:00\",\"dateModified\":\"2026-09-11T11:54:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/07\\\/21\\\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\\\/\"},\"wordCount\":104,\"image\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/07\\\/21\\\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Image1222.png\",\"articleSection\":[\"Actualit\u00e9\",\"Other news\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/07\\\/21\\\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\\\/\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/07\\\/21\\\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\\\/\",\"name\":\"THE LATEST ISSUE OF MABDESIGN\u2019S IMMUNOWATCH, DEDICATED TO RADIOPHARMACEUTICALS, IS NOW AVAILABLE! - Atonco\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/07\\\/21\\\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/07\\\/21\\\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Image1222.png\",\"datePublished\":\"2026-07-21T11:36:32+00:00\",\"dateModified\":\"2026-09-11T11:54:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/c77adc54665cc7fe725d486b08371aaa\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/07\\\/21\\\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/07\\\/21\\\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/07\\\/21\\\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\\\/#primaryimage\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Image1222.png\",\"contentUrl\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Image1222.png\",\"width\":625,\"height\":815},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2026\\\/07\\\/21\\\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"THE LATEST ISSUE OF MABDESIGN\u2019S IMMUNOWATCH, DEDICATED TO RADIOPHARMACEUTICALS, IS NOW AVAILABLE!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/\",\"name\":\"Atonco\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/c77adc54665cc7fe725d486b08371aaa\",\"name\":\"Elise\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c23dfecedb59d117a210ee9085db49be7a0b6ab970784f240f5e45c2a8185ea9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c23dfecedb59d117a210ee9085db49be7a0b6ab970784f240f5e45c2a8185ea9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c23dfecedb59d117a210ee9085db49be7a0b6ab970784f240f5e45c2a8185ea9?s=96&d=mm&r=g\",\"caption\":\"Elise\"},\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/author\\\/administration\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"THE LATEST ISSUE OF MABDESIGN\u2019S IMMUNOWATCH, DEDICATED TO RADIOPHARMACEUTICALS, IS NOW AVAILABLE! - Atonco","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/atonco-pharma.com\/en\/2026\/07\/21\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\/","og_locale":"en_US","og_type":"article","og_title":"THE LATEST ISSUE OF MABDESIGN\u2019S IMMUNOWATCH, DEDICATED TO RADIOPHARMACEUTICALS, IS NOW AVAILABLE! - Atonco","og_description":"This issue takes a deep dive into one of the most dynamic areas of precision oncology. MabDesign\u2019s Scientific and Business Intelligence Department kicks off the edition with an in-depth analysis of the market landscape, development pipeline, and industrial challenges shaping this consolidating sector. Leading experts then address critical topics: from bioconjugation strategies for radioimmunoconjugates to […]","og_url":"https:\/\/atonco-pharma.com\/en\/2026\/07\/21\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\/","og_site_name":"Atonco","article_published_time":"2026-07-21T11:36:32+00:00","article_modified_time":"2026-09-11T11:54:40+00:00","og_image":[{"width":625,"height":815,"url":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2026\/07\/Image1222.png","type":"image\/png"}],"author":"Elise","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Elise","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/atonco-pharma.com\/en\/2026\/07\/21\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\/#article","isPartOf":{"@id":"https:\/\/atonco-pharma.com\/en\/2026\/07\/21\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\/"},"author":{"name":"Elise","@id":"https:\/\/atonco-pharma.com\/en\/#\/schema\/person\/c77adc54665cc7fe725d486b08371aaa"},"headline":"THE LATEST ISSUE OF MABDESIGN\u2019S IMMUNOWATCH, DEDICATED TO RADIOPHARMACEUTICALS, IS NOW AVAILABLE!","datePublished":"2026-07-21T11:36:32+00:00","dateModified":"2026-09-11T11:54:40+00:00","mainEntityOfPage":{"@id":"https:\/\/atonco-pharma.com\/en\/2026\/07\/21\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\/"},"wordCount":104,"image":{"@id":"https:\/\/atonco-pharma.com\/en\/2026\/07\/21\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\/#primaryimage"},"thumbnailUrl":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2026\/07\/Image1222.png","articleSection":["Actualit\u00e9","Other news"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/atonco-pharma.com\/en\/2026\/07\/21\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\/","url":"https:\/\/atonco-pharma.com\/en\/2026\/07\/21\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\/","name":"THE LATEST ISSUE OF MABDESIGN\u2019S IMMUNOWATCH, DEDICATED TO RADIOPHARMACEUTICALS, IS NOW AVAILABLE! - Atonco","isPartOf":{"@id":"https:\/\/atonco-pharma.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/atonco-pharma.com\/en\/2026\/07\/21\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\/#primaryimage"},"image":{"@id":"https:\/\/atonco-pharma.com\/en\/2026\/07\/21\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\/#primaryimage"},"thumbnailUrl":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2026\/07\/Image1222.png","datePublished":"2026-07-21T11:36:32+00:00","dateModified":"2026-09-11T11:54:40+00:00","author":{"@id":"https:\/\/atonco-pharma.com\/en\/#\/schema\/person\/c77adc54665cc7fe725d486b08371aaa"},"breadcrumb":{"@id":"https:\/\/atonco-pharma.com\/en\/2026\/07\/21\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/atonco-pharma.com\/en\/2026\/07\/21\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/atonco-pharma.com\/en\/2026\/07\/21\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\/#primaryimage","url":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2026\/07\/Image1222.png","contentUrl":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2026\/07\/Image1222.png","width":625,"height":815},{"@type":"BreadcrumbList","@id":"https:\/\/atonco-pharma.com\/en\/2026\/07\/21\/le-nouveau-numero-dimmunowatch-de-mabdesign-consacre-aux-produits-radiopharmaceutiques-est-desormais-disponible\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/atonco-pharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"THE LATEST ISSUE OF MABDESIGN\u2019S IMMUNOWATCH, DEDICATED TO RADIOPHARMACEUTICALS, IS NOW AVAILABLE!"}]},{"@type":"WebSite","@id":"https:\/\/atonco-pharma.com\/en\/#website","url":"https:\/\/atonco-pharma.com\/en\/","name":"Atonco","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/atonco-pharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/atonco-pharma.com\/en\/#\/schema\/person\/c77adc54665cc7fe725d486b08371aaa","name":"Elise","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/c23dfecedb59d117a210ee9085db49be7a0b6ab970784f240f5e45c2a8185ea9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c23dfecedb59d117a210ee9085db49be7a0b6ab970784f240f5e45c2a8185ea9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c23dfecedb59d117a210ee9085db49be7a0b6ab970784f240f5e45c2a8185ea9?s=96&d=mm&r=g","caption":"Elise"},"url":"https:\/\/atonco-pharma.com\/en\/author\/administration\/"}]}},"_links":{"self":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/comments?post=1395"}],"version-history":[{"count":6,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1395\/revisions"}],"predecessor-version":[{"id":1421,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1395\/revisions\/1421"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/media\/1396"}],"wp:attachment":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/media?parent=1395"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/categories?post=1395"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/tags?post=1395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}